WorldQuant Millennium Advisors’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.57M Buy
+5,310
New +$1.4M ﹤0.01% 551
2025
Q2
– Sell
-21,768
Closed -$3.28M – 501
2025
Q1
$3.28M Sell
21,768
-110,658
-84% -$18.6M 0.02% 323
2024
Q4
$24.4M Buy
+132,426
New +$25.5M 0.16% 155
2023
Q4
– Sell
-21,473
Closed -$4.21M – 349
2023
Q3
$4.21M Buy
21,473
+9,257
+76% +$1.9M 0.07% 237
2023
Q2
$2.57M Buy
+12,216
New +$2.43M 0.04% 282

Other funds holding CRL

WorldQuant Millennium Advisors's CRL Position: Q3 2026 in Review

WorldQuant Millennium Advisors opened a new position in Charles River Laboratories (CRL) in Q3 2026: 5,310 shares worth $1.57M. The stake represents ﹤0.01% of the portfolio and ranks #551 among its holdings. This is a return to the name: WorldQuant Millennium Advisors previously reported a position in CRL as recently as Q1 2025.

WorldQuant Millennium Advisors first reported a position in CRL in Q2 2023 and has held it in 5 quarters since. The position peaked at $24.4M in Q4 2024. 646 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • WorldQuant Millennium Advisors held 5,310 shares of Charles River Laboratories worth $1.57M as of Q3 2026.
  • Charles River Laboratories was a new WorldQuant Millennium Advisors position in Q3 2026.
  • Charles River Laboratories made up ﹤0.01% of WorldQuant Millennium Advisors's portfolio in Q3 2026, its #551 holding.
  • WorldQuant Millennium Advisors first reported a position in Charles River Laboratories in Q2 2023 and has held it in 5 quarters since.
  • WorldQuant Millennium Advisors's Charles River Laboratories position peaked at $24.4M in Q4 2024.
  • 646 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.